Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• ‘Troubling numbers’ reveal pandemic’s toll on CVD deaths, widening race disparities Regina Schaffer; Scott Buzby
• 1.5 million atrial fibrillation cases may be undiagnosed in US Regina Schaffer
• 500 extra steps per day could reduce CV risk for adults 70 years and older Scott Buzby
• AI algorithm for detection of AAA nets FDA clearance
• AI-enhanced platform for detecting cardiac amyloidosis nets FDA breakthrough device status
• Black women with genetic variant for amyloidosis face substantial CVD, mortality risk Regina Schaffer
• Causal AI ‘translates’ CAD polygenic risk score into clinically actionable data Regina Schaffer
• COAPT: Benefits of MitraClip sustained to 5 years; death, HF events high Scott Buzby
• Consider revisiting reasons for anticoagulant nonuse among patients with AF Scott Buzby
• Data suggest Apple Watch appropriate for AF screening, but not disease management Regina Schaffer
• Douglass: Strides made in CV health equity, but much more needs to be accomplished Erik Swain; Paul L. Douglass, MD
• FDA extends approval of evinacumab for HoFH to children aged 5 to 11 years
• Heart roundness may be early marker of atrial fibrillation, cardiomyopathy Regina Schaffer
• Heart-lung machine nets FDA 510(k) clearance, launched in US
• Imaging data may predict best responders to evolocumab therapy: YELLOW III Regina Schaffer
• Lipoprotein(a): The next frontier in CV risk reduction Seth J. Baum, MD
• Mediterranean, low-fat diets may reduce death, heart attack in adults at elevated risk Erik Swain
• Most patients at high CV risk are not achieving LDL goals Erik Swain
• Noninvasive treatment improves cerebral blood flow, cognition in mild Alzheimer’s disease Regina Schaffer
• PCI utilization decreased but rebounded quickly during pandemic Regina Schaffer
• Polypill for blood pressure lowering may improve adherence and reduce mortality Scott Buzby
• Remote monitoring of cardiac devices during pandemic cut greenhouse gas emissions Regina Schaffer
• SGLT2 inhibitor therapy reduces sudden cardiac death risk in heart failure Regina Schaffer
• Improving safety, reducing length of stay for sotalol and dofetilide initiation in AF Tanvi Patil, PharmD, BCPS; Stacey Zysk, PharmD; Kezia Timmons, PharmD; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• BMAD-HF
• COORDINATE-Diabetes
• HOST-IDEA
• IMPLEMENT-HF
• LODESTAR
• OCEAN-LAAC
• RENOVATE-COMPLEX-PCI
• UK Mini Mitral